(Q51998727)

19 April 2018

title

Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. (English)

1 reference

19 April 2018

0 references

1 reference

10

Claire-Anne Siegrist

1 reference

19 April 2018

author name string

Anne-Cécile Rimaniol

1

1 reference

19 April 2018

Gabriel Gras

2

1 reference

19 April 2018

François Verdier

3

1 reference

19 April 2018

Francis Capel

4

1 reference

19 April 2018

Vladimir B Grigoriev

5

1 reference

19 April 2018

Fabrice Porcheray

6

1 reference

19 April 2018

Elisabeth Sauzeat

7

1 reference

19 April 2018

Jean-Guy Fournier

8

1 reference

19 April 2018

Pascal Clayette

9

1 reference

19 April 2018

Dominique Dormont

11

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 August 2004

1 reference

19 April 2018

published in

Vaccine

1 reference

19 April 2018

volume

22

1 reference

19 April 2018

issue

23-24

1 reference

19 April 2018

page(s)

3127-3135

1 reference

19 April 2018

In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

Central nervous system disease in patients with macrophagic myofasciitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

Aluminum phagocytosis in quadriceps muscle following vaccination in children: relationship to macrophagic myofasciitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

Na+-dependent high-affinity glutamate transport in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

Predicting the adsorption of proteins by aluminium-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

Either IL-2 or IL-12 is sufficient to direct Th1 differentiation by nonobese diabetic T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

Dendritic cells and the control of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.061

10.1016/J.VACCINE.2004.01.061

7 January 2021

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

15297065

1 reference

19 April 2018